In addition, IL-27 inhibited in vitro and in vivo growth of prostate cancer cells and tumor angiogenesis [33] and also triggered anti-angiogenic responses through the induction of anti-angiogenic chemokines in mouse melanoma models [66]. This evidence concerns the gene IL27 and prostate cancer.